2 child clusters
Sub-clusters inside Donor Testing & Laboratory Services. Each card links to its own detail page; counts are rolled up through the whole subtree of that child.
2 orgs in this cluster's subtree
Every organization with primary activities in Donor Testing & Laboratory Services or any of its descendants. Click a column header to sort. Filter by name or state above the table.
| # | Organization | State | Revenue | Activities ↓ |
|---|---|---|---|---|
| 1 | Creative Testing Solutions Creative Testing Solutions is a nonprofit organization that operates laboratories for infectious disease testing of blood and plasma donations. It serves healt… | AZ | $438.8M | 34 |
| 2 | United Tissue Network United Tissue Network is a nonprofit organization that facilitates whole body donation for medical research and education. The organization honors donors and t… | AZ | $4.9M | 4 |
strategies used in this cluster
Theories of action extracted from orgs in this subtree. Click any to see the full set of orgs running the same approach.
- Feedback-Driven Evolution 1 orgBy systematically collecting and acting on feedback from stakeholders, organizations improve the relevance and effectiveness of their services and governance, because ongoing input ensures alignment with community needs and fosters trust and ownership. This strategy centers on using continuous feedback—whether from clients, members, patients, or congregants—as a core mechanism for adaptation and improvement. It appears across diverse contexts, from healthcare and professional associations to faith-based and recreational organizations, unifying them around a shared belief that responsiveness to lived experience and participation drives impact. Unlike top-down or expert-led models, this approach treats stakeholder insight as essential data for decision-making, distinguishing it from static or output-focused operational practices.Creative Testing Solutions
- Translational Research Acceleration 1 orgBy bridging scientific discovery and clinical application through integrated research models, organizations accelerate medical innovation and improve patient outcomes, because reducing the gap between lab findings and real-world treatment enables faster, more effective solutions for unmet health needs. This strategy emphasizes a deliberate, structured pathway from basic science to clinical impact, unifying diverse efforts such as genomic analysis, biospecimen sharing, cross-species oncology, and bench-to-bedside collaboration. Unlike general research funding or isolated lab work, this approach prioritizes bidirectional flow between researchers and clinicians, ensuring that discoveries are not only scientifically sound but also clinically actionable. It is distinguished by its focus on process acceleration—via data standardization, pre-competitive collaboration, or rapid translation—rather than discovery alone.Creative Testing Solutions